Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment.
do Valle
Solange Oliveira Rodrigues
SO
França
Alfeu Tavares
AT
Pires
Gisele Vian
GV
Guimarães
Patrícia
P
Dias
Gabriela Andrade Coelho
GA
Levy
Solony Afra Pires
SA
D000328:Adult; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects*; D003715:Dengue / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D004890:Erythema; D005260:Female; D005334:Fever; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D006919:Hydroxyzine / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011537:Pruritus; D011899:Ranitidine / Q000008:administration & dosage; D014581:Urticaria
D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D006919:Hydroxyzine; D011899:Ranitidine; D003622:Dapsone; D011241:Prednisone